2026 Q1 -tulosraportti
Vain PDF
6 päivää sitten
Tarjoustasot
Spotlight Stock Market SE
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 248 | NON | NON | ||
| 898 | NON | ENS | ||
| 3 090 | NON | ENS | ||
| 12 | ENS | ENS | ||
| 988 | ENS | NON |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 72 766 | 14 999 | +57 767 | 6 548 |
| Swedbank AB | 6 000 | 0 | +6 000 | 0 |
| Nordea Bank Abp | 500 | 0 | +500 | 0 |
| Carnegie Investment Bank AB | 865 | 865 | 0 | 0 |
| Skandinaviska Enskilda Banken AB | 1 000 | 4 000 | −3 000 | 12 |
| Svenska Handelsbanken AB | 11 056 | 16 056 | −5 000 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Avanza Bank AB | 952 | 57 219 | −56 267 | 816 |
| Svenska Handelsbanken AB | 11 056 | 16 056 | −5 000 | 0 |
| Skandinaviska Enskilda Banken AB | 1 000 | 4 000 | −3 000 | 12 |
| Carnegie Investment Bank AB | 865 | 865 | 0 | 0 |
| Nordea Bank Abp | 500 | 0 | +500 | 0 |
| Swedbank AB | 6 000 | 0 | +6 000 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.7. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 30.4. | ||
2025 Q4 -tulosraportti 30.1. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 | ||
2025 Q1 -tulosraportti 21.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 päivää sittenExtremely tough with a new issue at 1.35 kr and today clearly lower, even down below one krona. Large turnover, so who subscribes and why? Good with guarantees, otherwise the company won't survive the future - that's how it is. Unfortunately, a stock exchange listing that has a minimum of 19 kr, so small shareholdings become expensive.
·1 päivä sittenMicropos is a company to own for the future for those who believe in the technology. I'm staying put, but don't expect any quick gains. The company has a super product for the treatment of prostate cancer. Swedes pay to get the treatment abroad, because Sweden is lagging behind when it comes to radiation. That says a lot about the product. Here, surgery is performed even if it carries a much greater risk of more serious side effects. The slow marketing is another thing that has also surprised Ove, but he continues to invest.- ·20.4.AI answer to what seems strange - the stock rises on the share issue announcement. "The stock rises because the share issue reduces the risk in the company, is almost fully guaranteed, and signals financial stability and confidence in the future. The market values the risk more than the discount."
- ·20.3.Yes, now some positive news is needed. A great product that is hard to sell due to the healthcare system's established routines. I asked a urologist if he had heard of the product and the answer was no. It is absolutely incredible that the information does not get through despite all positive published studies and experiences.·1.4.Slowly, slowly it moves forward... HM Sanchinarro University Hospital in Madrid has treated their first patient with the Raypilot System. The system was installed and their staff trained in February, with the first prostate treatment using ASBRT and Raypilot performed in March.
- 17.2.17.2.MDR Certification for Raypilot System Micropos Medical has received both MDR and UKCA certification for the Raypilot System. This confirms that the Raypilot System is now fully compliant with the EU Medical Device Regulation MDR 2017/745 as well as UK MDR 2002 for medical devices. Achieving this certification has been a comprehensive effort that required strong commitment and significant resources from the entire organization. Through close collaboration, meticulous documentation, and a shared focus, we have successfully met the demanding regulatory requirements. “Obtaining MDR certification is an extremely important milestone for us. It is proof that our products are safe and meet the strict standards required for medical devices. This certification is highly meaningful for us as a company, for our customers, and most importantly for patient safety. It also enables us to continue improving the product and expand further,” says Hanna Syrén, COO and QA/RA at Micropos Medical.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
6 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 päivää sittenExtremely tough with a new issue at 1.35 kr and today clearly lower, even down below one krona. Large turnover, so who subscribes and why? Good with guarantees, otherwise the company won't survive the future - that's how it is. Unfortunately, a stock exchange listing that has a minimum of 19 kr, so small shareholdings become expensive.·1 päivä sittenMicropos is a company to own for the future for those who believe in the technology. I'm staying put, but don't expect any quick gains. The company has a super product for the treatment of prostate cancer. Swedes pay to get the treatment abroad, because Sweden is lagging behind when it comes to radiation. That says a lot about the product. Here, surgery is performed even if it carries a much greater risk of more serious side effects. The slow marketing is another thing that has also surprised Ove, but he continues to invest.
- ·20.4.AI answer to what seems strange - the stock rises on the share issue announcement. "The stock rises because the share issue reduces the risk in the company, is almost fully guaranteed, and signals financial stability and confidence in the future. The market values the risk more than the discount."
- ·20.3.Yes, now some positive news is needed. A great product that is hard to sell due to the healthcare system's established routines. I asked a urologist if he had heard of the product and the answer was no. It is absolutely incredible that the information does not get through despite all positive published studies and experiences.·1.4.Slowly, slowly it moves forward... HM Sanchinarro University Hospital in Madrid has treated their first patient with the Raypilot System. The system was installed and their staff trained in February, with the first prostate treatment using ASBRT and Raypilot performed in March.
- 17.2.17.2.MDR Certification for Raypilot System Micropos Medical has received both MDR and UKCA certification for the Raypilot System. This confirms that the Raypilot System is now fully compliant with the EU Medical Device Regulation MDR 2017/745 as well as UK MDR 2002 for medical devices. Achieving this certification has been a comprehensive effort that required strong commitment and significant resources from the entire organization. Through close collaboration, meticulous documentation, and a shared focus, we have successfully met the demanding regulatory requirements. “Obtaining MDR certification is an extremely important milestone for us. It is proof that our products are safe and meet the strict standards required for medical devices. This certification is highly meaningful for us as a company, for our customers, and most importantly for patient safety. It also enables us to continue improving the product and expand further,” says Hanna Syrén, COO and QA/RA at Micropos Medical.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market SE
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 248 | NON | NON | ||
| 898 | NON | ENS | ||
| 3 090 | NON | ENS | ||
| 12 | ENS | ENS | ||
| 988 | ENS | NON |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 72 766 | 14 999 | +57 767 | 6 548 |
| Swedbank AB | 6 000 | 0 | +6 000 | 0 |
| Nordea Bank Abp | 500 | 0 | +500 | 0 |
| Carnegie Investment Bank AB | 865 | 865 | 0 | 0 |
| Skandinaviska Enskilda Banken AB | 1 000 | 4 000 | −3 000 | 12 |
| Svenska Handelsbanken AB | 11 056 | 16 056 | −5 000 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Avanza Bank AB | 952 | 57 219 | −56 267 | 816 |
| Svenska Handelsbanken AB | 11 056 | 16 056 | −5 000 | 0 |
| Skandinaviska Enskilda Banken AB | 1 000 | 4 000 | −3 000 | 12 |
| Carnegie Investment Bank AB | 865 | 865 | 0 | 0 |
| Nordea Bank Abp | 500 | 0 | +500 | 0 |
| Swedbank AB | 6 000 | 0 | +6 000 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.7. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 30.4. | ||
2025 Q4 -tulosraportti 30.1. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 | ||
2025 Q1 -tulosraportti 21.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
6 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.7. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 30.4. | ||
2025 Q4 -tulosraportti 30.1. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 | ||
2025 Q1 -tulosraportti 21.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 päivää sittenExtremely tough with a new issue at 1.35 kr and today clearly lower, even down below one krona. Large turnover, so who subscribes and why? Good with guarantees, otherwise the company won't survive the future - that's how it is. Unfortunately, a stock exchange listing that has a minimum of 19 kr, so small shareholdings become expensive.·1 päivä sittenMicropos is a company to own for the future for those who believe in the technology. I'm staying put, but don't expect any quick gains. The company has a super product for the treatment of prostate cancer. Swedes pay to get the treatment abroad, because Sweden is lagging behind when it comes to radiation. That says a lot about the product. Here, surgery is performed even if it carries a much greater risk of more serious side effects. The slow marketing is another thing that has also surprised Ove, but he continues to invest.
- ·20.4.AI answer to what seems strange - the stock rises on the share issue announcement. "The stock rises because the share issue reduces the risk in the company, is almost fully guaranteed, and signals financial stability and confidence in the future. The market values the risk more than the discount."
- ·20.3.Yes, now some positive news is needed. A great product that is hard to sell due to the healthcare system's established routines. I asked a urologist if he had heard of the product and the answer was no. It is absolutely incredible that the information does not get through despite all positive published studies and experiences.·1.4.Slowly, slowly it moves forward... HM Sanchinarro University Hospital in Madrid has treated their first patient with the Raypilot System. The system was installed and their staff trained in February, with the first prostate treatment using ASBRT and Raypilot performed in March.
- 17.2.17.2.MDR Certification for Raypilot System Micropos Medical has received both MDR and UKCA certification for the Raypilot System. This confirms that the Raypilot System is now fully compliant with the EU Medical Device Regulation MDR 2017/745 as well as UK MDR 2002 for medical devices. Achieving this certification has been a comprehensive effort that required strong commitment and significant resources from the entire organization. Through close collaboration, meticulous documentation, and a shared focus, we have successfully met the demanding regulatory requirements. “Obtaining MDR certification is an extremely important milestone for us. It is proof that our products are safe and meet the strict standards required for medical devices. This certification is highly meaningful for us as a company, for our customers, and most importantly for patient safety. It also enables us to continue improving the product and expand further,” says Hanna Syrén, COO and QA/RA at Micropos Medical.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market SE
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 248 | NON | NON | ||
| 898 | NON | ENS | ||
| 3 090 | NON | ENS | ||
| 12 | ENS | ENS | ||
| 988 | ENS | NON |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 72 766 | 14 999 | +57 767 | 6 548 |
| Swedbank AB | 6 000 | 0 | +6 000 | 0 |
| Nordea Bank Abp | 500 | 0 | +500 | 0 |
| Carnegie Investment Bank AB | 865 | 865 | 0 | 0 |
| Skandinaviska Enskilda Banken AB | 1 000 | 4 000 | −3 000 | 12 |
| Svenska Handelsbanken AB | 11 056 | 16 056 | −5 000 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Avanza Bank AB | 952 | 57 219 | −56 267 | 816 |
| Svenska Handelsbanken AB | 11 056 | 16 056 | −5 000 | 0 |
| Skandinaviska Enskilda Banken AB | 1 000 | 4 000 | −3 000 | 12 |
| Carnegie Investment Bank AB | 865 | 865 | 0 | 0 |
| Nordea Bank Abp | 500 | 0 | +500 | 0 |
| Swedbank AB | 6 000 | 0 | +6 000 | 0 |